The PROfound study or the arrival of personalised medicine in the treatment of prostate cancer

被引:1
|
作者
Houede, Nadine [1 ]
机构
[1] CHU Caremeau, Inst Cancerol Gard, INSERM, U1194, Nimes, France
关键词
D O I
10.1016/j.bulcan.2020.11.016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:448 / 448
页数:1
相关论文
共 50 条
  • [31] PERSONALISED MEDICINE FOR FAMILIAL HYPERCHOLESTEROLEMIA - PILOT STUDY
    Chora, J. R.
    Bourbon, M.
    ATHEROSCLEROSIS, 2021, 331 : E166 - E166
  • [32] Personalised cancer medicine: Future crafting in the genomic era
    Mukhina, Natalia
    SOCIOLOGY OF HEALTH & ILLNESS, 2023, 45 (03) : 711 - 712
  • [33] Personalised medicine - Plant produced vaccine tackles cancer
    Walter, Patrick
    CHEMISTRY & INDUSTRY, 2008, (15) : 7 - 7
  • [34] INVESTIGATING THE USE OF PERSONALISED MEDICINE IN CANCER TRIALS - AN UPDATE
    Hamilton, K. A.
    Wilson, T.
    VALUE IN HEALTH, 2014, 17 (07) : A660 - A660
  • [35] Establishing treatment optimisation as part of personalised medicine development
    Lacombe, Denis
    Quaglio, Gianluca
    Lejeune, Stephane
    Saesen, Robbe
    Rubig, Paul
    EUROPEAN JOURNAL OF CANCER, 2019, 113 : 96 - 97
  • [36] Basic cancer research is essential for the success of personalised medicine
    Yarden, Yosef
    Caldes, Carlos
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (12) : 2619 - 2620
  • [37] DNA microarrays in breast cancer: the promise of personalised medicine
    Ramaswamy, S
    Perou, CM
    LANCET, 2003, 361 (9369): : 1576 - 1577
  • [38] Personalised medicine and population health: breast and ovarian cancer
    Narod, Steven A.
    HUMAN GENETICS, 2018, 137 (10) : 769 - 778
  • [39] Personalised Medicine Lessons from Neurodegeneration to Cancer Preface
    El-Khamisy, Sherif
    PERSONALISED MEDICINE: LESSONS FROM NEURODEGENERATION TO CANCER, 2017, 1007 : V - V
  • [40] Breast cancer genome heterogeneity: a challenge to personalised medicine?
    Swanton, Charles
    Burrell, Rebecca A.
    Futreal, P. Andrew
    BREAST CANCER RESEARCH, 2011, 13 (01):